The Global Advanced Therapy Medicinal Products Market is expected to reach an estimated $19.9 billion by 2030

According to a market report by Lucintel, the future of the global advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets. The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030 from $9.3 billion in 2024 at a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases, and favorable regulatory environment and growing government support.

A more than 150 – page report is developed to understand trends, opportunity and forecast in advanced therapy medicinal products market to 2030 by product (cell therapy, CAR-T therapy, gene therapy, and tissue engineered product), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Within this market, tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.

Download sample by clicking on advanced therapy medicinal products market

North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.

Spark Therapeutics, Bluebird Bio, Novartis, Uniqure, Celgene Corporation, Gilead Lifesciences, Kolon Tissuegene, JCR Pharmaceuticals, Medipost, and Vericel Corporation are the major suppliers in the advanced therapy medicinal products market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cast visit Lucintel’sAnalytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1 972.636.5056

Explore Our Latest Publications

BRIC Composite

SMC Market

Epoxy Curing Agent Market

Global Flavor and Fragrance Market

Composite Repair and Rehab Market

Lithium Battery for Drone Market

New Robotics and Drone Market

Oil Plant Protection Drone Market

Passenger Drone Market

Nano Hydroxyapatite Market

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Comments on “The Global Advanced Therapy Medicinal Products Market is expected to reach an estimated $19.9 billion by 2030”

Leave a Reply

Gravatar